A Very Low Dose of CBD Reversed Stress-Related Brain Changes in Mice
Just 1 mg/kg of CBD partially reversed depressive-like symptoms in chronically stressed mice and fully restored mature synapses in the prefrontal cortex.
Quick Facts
What This Study Found
A very low dose of CBD (1 mg/kg) partially reversed behavioral effects of chronic stress in mice. Mass spectrometry showed improvements across multiple neurotransmitter systems, particularly glutamatergic and serotonergic pathways in the medial prefrontal cortex. Most strikingly, CBD completely restored mature synapse formation in the prefrontal cortex of stressed mice.
Key Numbers
1 mg/kg CBD dose (very low compared to typical research doses of 10-100 mg/kg); complete restoration of mature synapses in medial prefrontal cortex; improvements across glutamatergic and serotonergic pathways; current antidepressants ineffective for approximately 30% of patients
How They Did This
Mice were subjected to chronic stress to model depression-like symptoms, then treated with low-dose CBD (1 mg/kg). Brain regions were analyzed using mass spectrometry and microstructural experiments with double-labeling of F-Actin and VGlut1-positive clusters to assess synaptic integrity.
Why This Research Matters
Current antidepressants fail about 30% of patients and often cause significant side effects. This study suggests CBD may work at remarkably low doses through synaptic remodeling, a mechanism distinct from conventional antidepressants, potentially offering an alternative pathway for treatment-resistant depression.
The Bigger Picture
The finding that a very low CBD dose can restore synapses in the prefrontal cortex challenges the assumption that higher doses are needed for brain effects. If this translates to humans, effective CBD doses for depression could be far lower than what is currently available in consumer products.
What This Study Doesn't Tell Us
Mouse model of stress may not fully represent human depression, single dose tested, short-term treatment without long-term follow-up, specific mouse strain may not generalize, mechanism of CBD action at this low dose not fully elucidated
Questions This Raises
- ?Would similarly low CBD doses be effective in humans?
- ?How does the synaptic restoration mechanism compare to conventional antidepressant mechanisms?
- ?Would higher CBD doses produce different or better results?
Trust & Context
- Key Stat:
- CBD at just 1 mg/kg fully restored mature synapses in the prefrontal cortex of stressed mice
- Evidence Grade:
- Single animal study with novel findings at an unusually low dose; interesting mechanistic data but needs replication and human testing
- Study Age:
- Published 2025
- Original Title:
- Low-dose cannabidiol treatment prevents chronic stress-induced phenotypes and is associated with multiple synaptic changes across various brain regions.
- Published In:
- Neuropharmacology, 277, 110526 (2025)
- Authors:
- Borràs-Pernas, Sara, Sancho-Balsells, Anna, Patterer, Lisa, Wang, Maoyu, Del Toro, Daniel, Alberch, Jordi, Schibano, Daniele, Espel, Joan, Heybeck, Maya, Scheidel, Bernhard, Giralt, Albert
- Database ID:
- RTHC-06100
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD help with depression?
In mice, a very low dose of CBD reversed some effects of chronic stress and restored synaptic connections in the prefrontal cortex, a brain region central to mood regulation. Human studies have not yet confirmed these effects.
How much CBD was used in this study?
Just 1 mg/kg, which is remarkably low compared to the 10-100 mg/kg doses used in most animal CBD research. This suggests effective doses for brain effects might be much lower than previously assumed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06100APA
Borràs-Pernas, Sara; Sancho-Balsells, Anna; Patterer, Lisa; Wang, Maoyu; Del Toro, Daniel; Alberch, Jordi; Schibano, Daniele; Espel, Joan; Heybeck, Maya; Scheidel, Bernhard; Giralt, Albert. (2025). Low-dose cannabidiol treatment prevents chronic stress-induced phenotypes and is associated with multiple synaptic changes across various brain regions.. Neuropharmacology, 277, 110526. https://doi.org/10.1016/j.neuropharm.2025.110526
MLA
Borràs-Pernas, Sara, et al. "Low-dose cannabidiol treatment prevents chronic stress-induced phenotypes and is associated with multiple synaptic changes across various brain regions.." Neuropharmacology, 2025. https://doi.org/10.1016/j.neuropharm.2025.110526
RethinkTHC
RethinkTHC Research Database. "Low-dose cannabidiol treatment prevents chronic stress-induc..." RTHC-06100. Retrieved from https://rethinkthc.com/research/borras-pernas-2025-lowdose-cannabidiol-treatment-prevents
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.